A Multicenter Randomized Double-blind Clinical Study Evaluated the Safety, Pharmacokinetic and Pharmacodynamic Characteristics of Roflumilast in COPD Patients

PHASE2TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

June 13, 2018

Study Completion Date

June 13, 2018

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG

Roflumilast

DRUG

Placebo

Trial Locations (1)

First Affiliated Hospital of Guangzhou Medical University, Guangzhou